Laer S - Search Results

1

NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies.

Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, Koch A, Falkenberg J, Mir TS. Nir A, et al. Among authors: laer s. Pediatr Cardiol. 2009 Jan;30(1):3-8. doi: 10.1007/s00246-008-9258-4. Epub 2008 Jul 4. Pediatr Cardiol. 2009. PMID: 18600369 Review.

2

Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender.

Mir TS, Flato M, Falkenberg J, Haddad M, Budden R, Weil J, Albers S, Laer S. Mir TS, et al. Among authors: laer s. Pediatr Cardiol. 2006 Jan-Feb;27(1):73-77. doi: 10.1007/s00246-005-1022-4. Pediatr Cardiol. 2006. PMID: 16132298

3

Utility of N-terminal brain natriuretic peptide plasma concentrations in comparison to lactate and troponin in children with congenital heart disease following open-heart surgery.

Mir TS, Haun C, Lilje C, Läer S, Weil J. Mir TS, et al. Among authors: laer s. Pediatr Cardiol. 2006 Mar-Apr;27(2):209-16. doi: 10.1007/s00246-005-1152-8. Pediatr Cardiol. 2006. PMID: 16391984

4

Levels of brain natriuretic peptide in children with right ventricular overload due to congenital cardiac disease.

Mir TS, Falkenberg J, Friedrich B, Gottschalk U, Lê TP, Laer S, Weil J. Mir TS, et al. Among authors: laer s. Cardiol Young. 2005 Aug;15(4):396-401. doi: 10.1017/S1047951105000831. Cardiol Young. 2005. PMID: 16014188

5

N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability.

Albers S, Mir TS, Haddad M, Läer S. Albers S, et al. Among authors: laer s. Clin Chem Lab Med. 2006;44(1):80-5. doi: 10.1515/CCLM.2006.016. Clin Chem Lab Med. 2006. PMID: 16375591

6

Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure.

Mir TS, Marohn S, Läer S, Eiselt M, Grollmus O, Weil J. Mir TS, et al. Among authors: laer s. Pediatrics. 2002 Dec;110(6):e76. doi: 10.1542/peds.110.6.e76. Pediatrics. 2002. PMID: 12456943 Clinical Trial.

7

Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth.

Mir TS, Laux R, Hellwege HH, Liedke B, Heinze C, von Buelow H, Läer S, Weil J. Mir TS, et al. Among authors: laer s. Pediatrics. 2003 Oct;112(4):896-9. doi: 10.1542/peds.112.4.896. Pediatrics. 2003. PMID: 14523183

8

Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia.

Läer S, Elshoff JP, Meibohm B, Weil J, Mir TS, Zhang W, Hulpke-Wette M. Läer S, et al. J Am Coll Cardiol. 2005 Oct 4;46(7):1322-30. doi: 10.1016/j.jacc.2005.06.061. J Am Coll Cardiol. 2005. PMID: 16198851 Free article.

9

Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure.

Albers S, Meibohm B, Mir TS, Läer S. Albers S, et al. Among authors: laer s. Br J Clin Pharmacol. 2008 Apr;65(4):511-22. doi: 10.1111/j.1365-2125.2007.03046.x. Epub 2007 Nov 8. Br J Clin Pharmacol. 2008. PMID: 17995971 Free PMC article. Clinical Trial.

10

Effect of Carvedilol on QT Duration in Paediatric Patients with Congestive Heart Failure.

Mir TS, Läer S, Eiselt M, Falkenberg J, Gottschalk U, Weil J. Mir TS, et al. Among authors: laer s. Clin Drug Investig. 2004;24(1):9-15. doi: 10.2165/00044011-200424010-00002. Clin Drug Investig. 2004. PMID: 17516686

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters